Lv41
498 积分 2025-11-21 加入
Elevated levels of TL1A are associated with disease activity in patients with systemic sclerosis
8天前
已完结
Establishing a flow cytometry‐based tissue receptor occupancy assay for an anti‐oncostatin M receptor beta subunit therapeutic candidate in inflammatory bowel disease
17天前
已完结
Differential therapeutic implications of the OSM-OSMR signaling pathway in cancer and inflammatory diseases
22天前
已完结
Increased levels of the soluble oncostatin M receptor (sOSMR) and glycoprotein 130 (sgp130) in systemic sclerosis patients and associations with clinical parameters
1个月前
已完结
Soluble oncostatin M receptor (sOSMR): A potential biomarker in systemic sclerosis diagnosis
1个月前
已完结
Oncostatin M Induces a Pro-inflammatory Phenotype in Intestinal Subepithelial Myofibroblasts
3个月前
已完结
Mouse models of inflammatory bowel disease☆
3个月前
已完结
The emerging role of BLyS/APRIL in autoimmune diseases: Biological characteristics, functions, and therapeutic potential
4个月前
已完结
Extracellular targeted protein degradation: an emerging modality for drug discovery
4个月前
已完结
Bifunctional LYTAC Mediates Hepatocytes-Hepatic Stellate Cells Crosstalk by Regulating 5-HT 2A Receptor Degradation and Antagonism to Synergistically Ameliorate Hepatic Fibrosis
5个月前
已完结
皖公网安备34019202002308
